Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Compérat

Showing results (231-240 of 243) with videos related to

Pageof 25
Sort By:
Histopathology|March 31, 2016
Gleason grade 4 prostate adenocarcinoma patterns: an interobserver agreement study among genitourinary pathologistsCharlotte F Kweldam, Daan Nieboer, Ferran Algaba, et al.
European Urology Focus|January 19, 2021
Prognostic Impact of pT3 Subclassification in a Multicentre Cohort of Patients with Urothelial Carcinoma of the Renal Pelvicalyceal System Undergoing Radical Nephroureterectomy: A Propensity Score-weighted Analysis After Central Pathology ReviewThomas Seisen, Andrea Mari, Riccardo Campi, et al.
European Urology Oncology|January 29, 2025
A Systematic Review and Meta-analysis of the Clinical Impact of Prophylactic Quinolones with Adjuvant Bacillus Calmette-Guérin Instillation for Non-muscle-invasive Bladder CancerChris Ho-Ming Wong, Ivan Ching-Ho Ko, David Ka-Wai Leung, et al.
BJU International|February 5, 2025
Refining partial gland ablation for localised prostate cancer: the FALCON projectLara Rodriguez-Sanchez, Xavier Cathelineau, Theo M de Reijke, et al.
BJU International|July 25, 2023
Prognostic value of programmed death ligand-1 and programmed death-1 expression in patients with upper tract urothelial carcinomaLuca Campedel, Eva Compérat, Géraldine Cancel-Tassin, et al.
European Urology Oncology|April 30, 2025
Assessment of the Prognostic and Predictive Values of the Deficient Mismatch Repair Phenotype in Patients Treated with Radical Nephroureterectomy for Upper Tract Urothelial CarcinomaPierre-Etienne Gabriel, Eva Compérat, Géraldine Cancel-Tassin, et al.
Histopathology|July 4, 2025
Interobserver reproducibility of hilar soft tissue invasion in testicular germ cell tumours among genitourinary pathologistsDouglas Jian-Xian Wu, Mahmut Akgul, Sean R Williamson, et al.
American Journal of Clinical Pathology|December 25, 2024
Urothelial carcinoma in situ with "early papillary formation" vs "lateral spread/shoulder lesion" of prior high-grade noninvasive papillary urothelial carcinoma: A survey of pathologist and urologist interpretationsAnkur R Sangoi, Ali Shahabi, Michelle S Hirsch, et al.
Lancet (London, England)|April 7, 2024
The Lancet Commission on prostate cancer: planning for the surge in casesNicholas D James, Ian Tannock, James N'Dow, et al.
Advances in Anatomic Pathology|June 15, 2021
The Genitourinary Pathology Society Update on Classification of Variant Histologies, T1 Substaging, Molecular Taxonomy, and Immunotherapy and PD-L1 Testing Implications of Urothelial CancersEva Compérat, Mahul B Amin, Jonathan I Epstein, et al.
Pageof 25

Showing results (231-240 of 243) with videos related to

Sort By:
Pageof 25
Histopathology|March 31, 2016
Gleason grade 4 prostate adenocarcinoma patterns: an interobserver agreement study among genitourinary pathologistsCharlotte F Kweldam, Daan Nieboer, Ferran Algaba, et al.
European Urology Focus|January 19, 2021
Prognostic Impact of pT3 Subclassification in a Multicentre Cohort of Patients with Urothelial Carcinoma of the Renal Pelvicalyceal System Undergoing Radical Nephroureterectomy: A Propensity Score-weighted Analysis After Central Pathology ReviewThomas Seisen, Andrea Mari, Riccardo Campi, et al.
European Urology Oncology|January 29, 2025
A Systematic Review and Meta-analysis of the Clinical Impact of Prophylactic Quinolones with Adjuvant Bacillus Calmette-Guérin Instillation for Non-muscle-invasive Bladder CancerChris Ho-Ming Wong, Ivan Ching-Ho Ko, David Ka-Wai Leung, et al.
BJU International|February 5, 2025
Refining partial gland ablation for localised prostate cancer: the FALCON projectLara Rodriguez-Sanchez, Xavier Cathelineau, Theo M de Reijke, et al.
BJU International|July 25, 2023
Prognostic value of programmed death ligand-1 and programmed death-1 expression in patients with upper tract urothelial carcinomaLuca Campedel, Eva Compérat, Géraldine Cancel-Tassin, et al.
European Urology Oncology|April 30, 2025
Assessment of the Prognostic and Predictive Values of the Deficient Mismatch Repair Phenotype in Patients Treated with Radical Nephroureterectomy for Upper Tract Urothelial CarcinomaPierre-Etienne Gabriel, Eva Compérat, Géraldine Cancel-Tassin, et al.
Histopathology|July 4, 2025
Interobserver reproducibility of hilar soft tissue invasion in testicular germ cell tumours among genitourinary pathologistsDouglas Jian-Xian Wu, Mahmut Akgul, Sean R Williamson, et al.
American Journal of Clinical Pathology|December 25, 2024
Urothelial carcinoma in situ with "early papillary formation" vs "lateral spread/shoulder lesion" of prior high-grade noninvasive papillary urothelial carcinoma: A survey of pathologist and urologist interpretationsAnkur R Sangoi, Ali Shahabi, Michelle S Hirsch, et al.
Lancet (London, England)|April 7, 2024
The Lancet Commission on prostate cancer: planning for the surge in casesNicholas D James, Ian Tannock, James N'Dow, et al.
Advances in Anatomic Pathology|June 15, 2021
The Genitourinary Pathology Society Update on Classification of Variant Histologies, T1 Substaging, Molecular Taxonomy, and Immunotherapy and PD-L1 Testing Implications of Urothelial CancersEva Compérat, Mahul B Amin, Jonathan I Epstein, et al.
Pageof 25